Analyst firms · Morgan Stanley · SGEN
Morgan Stanley SGEN price target and rating history
Seagen Inc. (SGEN) · Health Care
Morgan Stanley rates Seagen Inc. (SGEN) Overweight with a $170 price target, as of its latest action on Feb 10, 2022. It has published 5 rating actions on SGEN since July 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Overweight
- Price target
- $170
- Median target, all firms
- Too few
- Actions on SGEN
- 5
Morgan Stanley price target on SGEN
Every Morgan Stanley rating on SGEN
- Feb 10, 2022
- Jan 31, 2022
- Jan 18, 2022
- Oct 29, 2021
- Jul 16, 2021
Questions about Morgan Stanley and SGEN
- What is Morgan Stanley's price target for SGEN?
- Morgan Stanley's latest stated price target for Seagen Inc. (SGEN) is $170, from its action on Feb 10, 2022.
- What is Morgan Stanley's rating on SGEN?
- Morgan Stanley rates SGEN Overweight, a bullish rating, as of Feb 10, 2022.
- When did Morgan Stanley last change its view on SGEN?
- On Feb 10, 2022, Morgan Stanley cuts its price target to $170 from $175, keeps Overweight.
More SGEN rating histories
All Morgan Stanley ratingsSGEN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.